October brought several updates in the lung cancer field, ranging from notable trial results to patient-centered perspectives ...

CureWise, the AI-powered platform Steve originally developed to help with his own rare blood cancer diagnosis, has evolved ...

Jeannine Walston has a survivorship story of more than 25 years to share. Walston, who has contributed to CURE as a blogger ...

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. The U.S. Food and ...

Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.

‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old. A new book aims to educated young ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...

The subsequent treatment involved intensive procedures, including five rounds of chemotherapy, external beam radiation, and ...

HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone ...

Caregivers must respect the autonomy of adult patients, balancing support with allowing them to lead their own cancer journey ...